China Medical Monitor Industry Report, 2014-2017
- Hard Copy
- Single User License
- Enterprise-wide License
(PDF Printable & Editable)
- Hard Copy + Single User License
With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market size grew at a CAGR of 21.5%, to RMB4.69 billion in 2013. However, the medical monitor penetration in China was still at a relatively lower level, at 26.5% in 2013, far below the US level of 80%, reflecting great development potential. It is projected that by 2017 the market size of medical monitor industry in China will exceed RMB10 billion.
At present, most medical monitor enterprises in China are still very small and have weak R&D capabilities, and the market is dominated by Mindray, Philips, and GE, which occupy a combined share of roughly 80% in China medical monitor market. Moreover, Philips and GE enjoy absolute superiority in Chinese market of medium and high-end monitors. But under the backdrop of medical reform in China, foreign companies are also expanding their presence in medium and low-end market. For example, GE planned to raise the proportion of medium and high-end monitors and low-end ones in China 50%:50% by 2015.
As a leader in China’s medical monitor industry, Mindray took a 37% market share at home in 2013. Currently, the company is stepping up the expansion in China’s high-end monitor market. Compared with medical imaging system and in-vitro Diagnostics, however, Mindray’s revenue from monitoring products showed a slowdwon in growth rate, with the revenue proportion falling from 44% in 2009 to 36% in the first three quarters of 2014.
Biolight and EDAN Instruments have long been among the second echelon of medical monitor market in China, each with market share of less than 5%. Because of the increasingly intense competition in monitor market and difficulty in surpassing such monitor giants as Mindray, Philips, and GE, the second-echelon enterprises are accelerating the differentiated product layout. And Biolight, hoping to consolidate the medical monitoring product line, continuously improved the hematodialysis layout through M&A, and has completed the layout of the wearable products integrating smartness and mobile health care. In comparison, EDAN Instruments aggressively developed color Doppler ultrasound and POCT businesses, and has successively established 2 related subsidiaries in the United States.
Source: China Medical Monitor Industry Report, 2014-2017; ResearchInChina
China Medical Monitor Industry Report, 2014-2017 is primarily concerned with the following:
Development, market size, competitive landscape, import & export, development prediction of medical monitor industry in China;
Regulatory policy, industry policy, access barrier of medical monitors in China and the impact from upstream and downstream sectors, etc.;
Operation and medical monitor business of 4 global and 6 major Chinese monitor manufacturers, etc..
1. Overview of Medical Monitor Industry
2. Status Quo of Medical Monitor Industry
2.1 Medical Device Market
2.2 Market Size
2.3 Product Segments
2.3.1 Multi-parameter Monitor
2.3.2 Obstetric Monitor
2.4 Imports & Exports
2.5 Competitive Landscape
2.7 Entry Barriers
2.7.1 Market Access Barriers
2.7.2 Technical Barriers
2.7.3 Capital Barriers
2.7.4 Talent Barriers
2.8 Technological Level and Trend
2.8.1 Modular Technology
2.8.2 Complete Machine Technology
2.8.3 Informatization Technology
3. Development Environment of Medical Monitors in China
3.1 Policy Environment
3.1.1 Industrial Planning
3.1.2 Regulatory Policy
3.1.3 Import & Export Policy
3.2 Upstream and Downstream Sectors
3.2.1 Upstream Sectors
3.2.2 Downstream Sectors
4. Major Medical Monitor Enterprises
4.1.3 Monitor Business
4.1.4 Development in China
4.2.4 Development in China
4.3 Nihon Kohden Corp.
4.3.3 Revenue Structure
4.3.5 Business in China
4.4 Fukuda Denshi Co., Ltd.
4.4.3 Revenue Structure
4.4.4 Monitor Business
4.4.5 Business in China
4.5 Mindray Medical International Limited
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 R&D and Investment
4.5.6 Medical Monitor Business
4.5.7 Prediction and Outlook
4.6 Guangdong Biolight Meditech Co., Ltd.
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 R&D and Investment
4.6.6 Medical Monitor Business
4.6.7 Prediction and Outlook
4.7 EDAN Instruments, Inc.
6.7.3 Revenue Structure
6.7.4 Gross Margin
6.7.6 Medical Monitor Business
6.7.7 Prediction and Outlook
4.8 Shenzhen Creative Industry Co., Ltd.
4.9 Beijing Choice Electronic Tech Co., Ltd
4.10 Tianrong Medical & Communication Equipment Co.,Ltd
5. Summary and Forecast
5.1 Market Overview
5.2 Enterprise Analysis
Categories of Medical Monitor
Market Size of Medical Devices in China, 2011-2014
Number of Diagnostic, Monitoring, and Therapeutic Equipment Manufacturers in China, 2006-2014
Revenue and Profit of Diagnostic, Monitoring, and Therapeutic Equipment Manufacturing in China, 2006-2014
Market Size of Medical Monitors in China, 2007-2014
Market Structure of Medical Monitors in China by Product, 2013
Market Size of Multi-parameter Monitors in China, 2007-2014
Market Size of Obstetric Monitors in China, 2007-2014
Import Volume of Medical Monitors in China, 2007-2014
Import Value of Medical Monitors in China, 2007-2014
Average Import Price of Medical Monitors in China, 2007-2014
Import Volume, Import Value, and Unit Import Price for China’s Top 10 Medical Monitor Import Sources by Value, 2013
Export Volume of Medical Monitors in China, 2007-2014
Export Value of Medical Monitors in China, 2007-2014
Average Export Price of Medical Monitors in China, 2007-2014
Export Volume, Export Value, and Unit Export Price for China’s Top 10 Medical Monitor Export Destinations by Value, 2013
Proportion of Medical Monitors from Different Chinese Provinces/Municipalities in Total Nationwide by Export Value, 2013
Market Share of Major Medical Monitor Enterprises in China, 2013
Gross Margin of Major Medical Monitor Enterprises in China, 2007-2013
Planning for Medical Monitor Industry in China, 2006-2013
Number and YoY Growth of Hospitals in China, 2005-2013
Number of Medical Institutions and Hospital Beds in China, 2012-2013
China’s Health Expenditure and % of GDP, 1980-2013
China’s Health Care Spending Structure, 2005-2013
Number of Over-65s and % of Total Population in China, 2004-2013
Per Capita Disposable Income of Urban and Rural Households in China, 2006-2014
Per Capita Health Care Spending of Urban Chinese and % of Living Expenses, 2006-2012
Per Capita Health Care Spending of Rural Chinese and % of Living Expenses, 2006-2012
Supportive Policies for Constructing County-level Hospitals, 2009-2014
Revenue and Net Income of GE, 2009-2014
Revenue Structure of GE Healthcare, 2008-2014
Revenue and Profit of GE Healthcare, 2008-2014
Revenue and EBIT of Phillips, 2009-2014
Phillips Healthcare Business
Philips Healthcare’s Revenue and % of Total Revenue, 2009-2014
Revenue Structure of Philips Healthcare by Product, 2010-2013
Revenue of Philips Healthcare by Region, 2009-2013
Revenue of Philips in China and YoY Growth, 2011-2014
Revenue and Net Income of Nihon Kohden Corp., FY2009-FY2014
Gross Margin of Nihon Kohden Corp., FY2009-FY2014
Revenue of Nihon Kohden Corp. by Product, FY2009-FY2014
Revenue of Nihon Kohden Corp. by Region, FY2009-FY2014
Monitor Revenue and YoY Growth of Nihon Kohden Corp., FY2009-FY2014
Revenue and Net Income of Fukuda Denshi, FY2009-FY2014
Business Segments of Fukuda Denshi
Revenue of Fukuda Denshi by Product, FY2009-FY2014
Monitor Revenue and YoY Growth of Fukuda Denshi, FY2009-FY2014
Fukuda Denshi’s Main Monitor Products in China
Major Subsidiaries of Mindray Medical International as of the End of March 2014
Revenue and Net Income of Mindray Medical International, 2009-2014
Revenue of Mindray Medical International by Product, 2009-2014
Revenue Structure of Mindray Medical International by Product, 2009-2013
Revenue of Mindray Medical International by Region, 2009-2014
Revenue Structure of Mindray Medical International by Region, 2009-2014
Gross Margin of Mindray Medical International, 2009-2014
Mindray Medical International’s R&D Costs and % of Total Revenue, 2009-2014
Mindray’s Revenue and Gross Margin of Patient Monitoring & Life Support, 2009-2014
Revenue and Net Income of Mindray Medical International, 2013-2017E
Revenue and Net Income of Biolight, 2009-2014
Revenue of Biolight by Product, 2009-2014
Revenue of Biolight by Region, 2009-2014
Gross Margin of Biolight, 2009-2014
Gross Margin of Biolight by Product, 2009-2014
Biolight’s R&D Costs and % of Total Revenue, 2010-2014
Monitor Revenue and Gross Margin of Biolight, 2009-2014
Revenue and Gross Margin of Biolight by Product, 2009-2013
Revenue and Net Income of Biolight, 2013-2017E
Revenue and Net Income of EDAN Instruments, 2009-2014
Revenue of EDAN Instruments by Product, 2009-2014
Revenue of EDAN Instruments by Region, 2009-2014
Gross Margin of EDAN Instruments, 2009-2013
Gross Margin of EDAN Instruments by Product, 2009-2014
EDAN Instruments’ R&D Costs and % of Total Revenue, 2011-2014
Revenue and Gross Margin of Multi-parameter Monitor of EDAN Instruments, 2009-2014
Revenue and Net Income of EDAN Instruments, 2013-2017E
Revenue and Total Profit of Shenzhen Creative, 2007-2009
Gross Margin of Shenzhen Creative, 2007-2009
Total Assets and Total Liabilities of Shenzhen Creative, 2007-2009
Revenue and Total Profit of Beijing Choice, 2007-2009
Gross Margin of Beijing Choice, 2007-2009
Total Assets and Total Liabilities of Beijing Choice, 2007-2009
Revenue and Total Profit of Tianrong Medical, 2007-2009
Gross Margin of Tianrong Medical, 2007-2009
Total Assets and Total Liabilities of Tianrong Medical, 2007-2009
Penetration of Medical Monitors in China, 2007-2017E
Market Size of Medical Monitors in China, 2013-2017E
China Aged Care Industry Report, 2014-2017
According to the UN standard (the elderly people aged over 60 accounting for 10% of total population or the elderly people over age 65 occupying 7% of total population in one region), China entered th...
China Dental Industry Report, 2014-2018
Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...
China Medical Monitor Industry Report, 2014-2017
With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...
China Independent Clinical Laboratory Industry Report, 2014-2017
The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...
China Interventional Cardiovascular Device Industry Report,2014-2017
The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...
China PTCA Balloon Market Investment Report, 2014-2016
PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...
China Orthopedic Instrument Industry Report, 2014-2017
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...
China Hospital Development and Investment Report, 2014-2017
China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...
China Diagnostic Reagent Industry Report, 2013-2016
With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...
China Hemodialysis Equipment Import and Export Report, 2013-2016
Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...
Global and China Hemodialysis Industry Report, 2013-2016
Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure.
In 2013, the global number of patient...
China Portable Medical Equipment Industry Report, 2013-2016
With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...
China Medical Informatization Industry Report,2013-2016
Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...
China Aged Care Industry Report, 2013-2016
Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...
China Pharmaceutical Equipment Industry Report, 2013-2016
After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...
China Dental Industry Report, 2013-2016
The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...
China Medical Monitor Industry Report, 2013-2015
In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...
China Interventional Cardiovascular Device Industry Report, 2013-2015
With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...